𝔖 Bobbio Scriptorium

✦ LIBER ✦

The Timing of Preclinical Toxicological Studies: Pharmaceutical Company Approaches to Toxicity Testing in Support of Initial Clinical Investigations

✍ Scribed by Christopher Parkinson; Kate E. Thomas; Cyndy E. Lumley

Book ID: 115646561
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 191 KB
Volume: 23
Category: Article
ISSN: 0273-2300
DOI: 10.1006/rtph.1996.0038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Timing of Toxicological Studies to S

The Timing of Toxicological Studies to Support Clinical Trials || The duration of toxicity studies required to support repeated dosing in humans in clinical investigation

✍ Parkinson, Christopher; McAuslane, Neil; Lumley, Cyndy; Walker, Stuart 📂 Article 📅 1994 🏛 Springer Netherlands ⚖ 710 KB

The timing of toxicity studies in relati

The timing of toxicity studies in relation to clinical investigation

✍ Parkinson, C.; Thomas, K.; McAuslane, N.; Lumley, C.E. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 119 KB

A Comprehensive Guide to Toxicology in P

A Comprehensive Guide to Toxicology in Preclinical Drug Development || The Preparation of a Preclinical Dossier to Support an Investigational New Drug (IND) Application and First-in-Human Clinical Trial

✍ Nugent, Paul 📂 Article 📅 2013 🏛 Elsevier ⚖ 383 KB

Phospholine Iodide (217MI) and Demecariu

Phospholine Iodide (217MI) and Demecarium Bromide (BC48) in the Management of Glaucoma* *From the Glaucoma Clinic, University Hospital. This study was supported by Dominion-Provincial Grant No. 607-9-160. Based on a paper read to the Canadian Ophthalmological Society, October, 1959. Phospholine Iodide was kindly supplied by Campbell Pharmaceutical Company, New York. Demecarium Bromide was kindly supplied by Merck, Sharp and Dohme Company, Montreal, Canada.

✍ Drance, S.M. 📂 Article 📅 1960 🏛 Elsevier Science 🌐 English ⚖ 690 KB